Waking up, beautiful morning, getting ready for the customary spanking on the markets later on 🫠

Working with @citrini, we asked Claude to design proteins that bind to five scorpion toxins (covering the part of the toxin that latches onto cells). Over the next 64 hours, Claude generated over 300,000 designs; we sent 211 to @adaptyvbio and @TwistBioscience for lab testing.

"Think of it as the opposite of HSBC. They were banking the cartels, desperately trying to avoid government interventions that would make that clear to the public markets." @PalmerLuckey explains how Erebor is different from every other bank: "Put Erebor at the other end of that spectrum." "There are a lot of banks that — whether they are good or bad people is irrelevant — you might have good people who nonetheless are very beholden to European markets, Chinese markets, other foreign markets that they need to keep happy. Either because they want to keep them happy to make money, or because they don't want their executives in those jurisdictions to get arrested." "Erebor is taking a very different approach. We're an American company, we're an American bank, that supports American companies, and we will comply with US law, but we will not comply with spurious rulings from people who have no real jurisdiction or authority over us. And you'll have a very hard time finding a bank that takes that position. I'm not aware of any other than us."

Remarkable alpha: dismiss the study’s lead scientist’s warnings about small N and mean reversion a week before the data, add more, watch your pet stock crater 60%, then ridicule the guy who traded the pump while you bagheld the dump. 🤡 Watch the cycle repeat if it's approved.